Cite
HARVARD Citation
Rascol, O. et al. (2022). Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies. Parkinsonism & related disorders. pp. 65-73. [Online].